First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...
In a groundbreaking study published in Nature, Australian scientists have resolved a long-standing problem in regenerative medicine. Led by Professor Ryan Lister from the Harry Perkins Institute of ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...